NEW YORK, July 6 (GenomeWeb News) - Japanese distributor J.K. International will sell CombiMatrix microarrays in Japan, CombiMatrix parent company Acacia Research said today.

 

Under the terms of the non-exclusive agreement, J.K. International will market, sell, and service CombiMatrix' CustomArray line of microarrays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.